Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Pro-glucagon' and Ligand = 'BDBM142023'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Pro-glucagon (Homo sapiens (Human))	BDBM142023 (US8927577, 4) Show SMILES CC(C)CC(Nc1ncc2ccc(F)cc2n1)c1ccc(cc1)C(=O)NCCC(O)=O Show InChI InChI=1S/C23H25FN4O3/c1-14(2)11-19(27-23-26-13-17-7-8-18(24)12-20(17)28-23)15-3-5-16(6-4-15)22(31)25-10-9-21(29)30/h3-8,12-14,19H,9-11H2,1-2H3,(H,25,31)(H,29,30)(H,26,27,28)	PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	7.36E+3	n/a	n/a	n/a	n/a	n/a	n/a	7.4	n/a
Pfizer Inc. US Patent					Assay Description The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...				US Patent US8927577 (2015) BindingDB Entry DOI: 10.7270/Q29S1PRV
					More data for this Ligand-Target Pair